Talecris’ Product Integrity Enhanced With Environmentally-friendly Shipping Containers
New Shipping Technology, Control Temp Blue™, Insulates Talecris Biotherapeutics’ Temperature-sensitive Critical Care Therapies
RESEARCH TRIANGLE PARK, N.C. (February 15, 2007) – Talecris Biotherapeutics has integrated environmentally-friendly insulated shipping containers into its cold chain supply. The fully degradable Control Temp Blue™ container, manufactured by R.N.C. Industries, Inc., will provide enhanced temperature protection necessary to safely transport Talecris’ critical care treatments for people with life-threatening disorders. Talecris’ products are delicate and temperature-sensitive, necessitating extra care during packaging and distribution to help ensure the safety and efficacy of the products.
“The integration of Control Temp Blue containers into our supply chain will enhance the integrity of our products and minimize any environmental impact from packaging and shipping – yet another indication of Talecris’ commitment to deliver the safest possible products to our customers,” said Jim Bacon, Director, Global Demand Planning & Customer Operations, Talecris Biotherapeutics, Inc.
At the forefront of the cold chain supply industry, Talecris meticulously controls shipping conditions by using the most innovative technologies to ensure the continued integrity of its products. Control Temp Blue sets an industry standard for its environmentally-friendly design. The shipping container insulation contains a blend of several natural minerals heated, spun into a fiber, and encapsulated in a biodegradable blue plastic. Talecris adopted this unique packaging solution to minimize environmental impact and reduce waste.
“Talecris Biotherapeutics leads the way by seeking improved and more earth-friendly technologies,” said Larry Clark, President, R.N.C. Industries, Inc. and Inventor, Control Temp Blue. “As both an important client and partner, Talecris supported R.N.C.’s efforts during the development and launch of Control Temp Blue.”
Aside from the environmental benefits, the new containers also offer:
- Longer temperature maintenance per inch of insulation
- Enhanced cushioning and shock protection, which is especially important for Talecris’ glass enclosed products
For more information, contact:
Lacy McMahon, Talecris Biotherapeutics
Tel.: 919.316.6316, Fax: 919.316.6673
E-mail: lacy.mcmahon@talecris.com
About R.N.C. Industries, Inc.
R.N.C. Industries, Inc. was founded in 1990 by Larry Clark in Norcross, GA. Mr. Clark’s vision for the company was to create an alternative thermal shipping solution that was measurably superior to industry standard products. Today, R.N.C. Industries is one of the fastest growing companies in the region with a diverse international customer base serving the pharmaceutical and biotech industries, food, chemical, aerospace, and many others.
Control Temp Blue™ is the most environmentally friendly insulated shipping container ever invented. The insulation is a blend of several natural minerals heated to a high temperature and spun into a fiber. It is then encapsulated in a biodegradable blue plastic. Designed to return to the earth upon disposal, it is the unique solution for companies whose vision is to minimize their environmental impact and reduce waste.
About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.
Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, and hemostasis. Talecris is proudly building upon a 60-year legacy of innovation and a commitment to improving the lives of people who rely on its therapeutic products. With an emphasis on scientific inquiry and technological excellence, Talecris is expanding its current portfolio of products, programs, and services through its own world-class product development organization as well as through strategic initiatives that leverage its strengths with those of its partners.
Talecris, with revenues of approximately $1.2 billion in 2007, is headquartered in biotech hub Research Triangle Park, N.C., and employs more than 4,000 talented people worldwide.
To learn more about Talecris and how our employees are making a difference in the lives of patients and the healthcare community, visit www.talecris.com.
|
